OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD ): Evidence from an umbrella review of meta‐analysis on randomized controlled trials
Ming Yue Wang, Kousalya Prabahar, Mihnea‐Alexandru Găman, et al.
Journal of Digestive Diseases (2023) Vol. 24, Iss. 6-7, pp. 380-389
Closed Access | Times Cited: 14
Ming Yue Wang, Kousalya Prabahar, Mihnea‐Alexandru Găman, et al.
Journal of Digestive Diseases (2023) Vol. 24, Iss. 6-7, pp. 380-389
Closed Access | Times Cited: 14
Showing 14 citing articles:
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
Xin Ding, Xu He, Bulang Tang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Xin Ding, Xu He, Bulang Tang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?
Anastasios Serbis, Stergios A. Pοlyzos, Stavroula Α. Paschou, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 988-1006
Open Access | Times Cited: 4
Anastasios Serbis, Stergios A. Pοlyzos, Stavroula Α. Paschou, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 988-1006
Open Access | Times Cited: 4
Identification and mechanism elucidation of medicative diet for food therapy XQCSY in NAFLD prevention: an integrative in silico study
Chenxi Ren, Mingyuan Gao, Ning Li, et al.
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420015-9420015
Closed Access | Times Cited: 4
Chenxi Ren, Mingyuan Gao, Ning Li, et al.
Food & medicine homology. (2024) Vol. 1, Iss. 2, pp. 9420015-9420015
Closed Access | Times Cited: 4
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study
Yu Song, Wenjing Ni, Ming‐Hua Zheng, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101939-101939
Open Access
Yu Song, Wenjing Ni, Ming‐Hua Zheng, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101939-101939
Open Access
Research Progress of the Prevention and Treatment of Metabolic Associated Fatty Liver Disease as a Complication Disease of Endocrine Therapy for Breast Cancer
胜鹏 覃
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 581-590
Closed Access
胜鹏 覃
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 581-590
Closed Access
Negative association of composite dietary antioxidant index with risk of hepatic fibrosis in individuals underwent cholecystectomy: a cross-sectional study
Shuyao Hua, Wen Zhong, Yuanpu Sha, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Shuyao Hua, Wen Zhong, Yuanpu Sha, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Metabolic-associated fatty liver disease and sarcopenia: A double whammy
Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 152-163
Open Access | Times Cited: 3
Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 152-163
Open Access | Times Cited: 3
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Vitamin E in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Stergios A. Pοlyzos, Jannis Kountouras
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
Stergios A. Pοlyzos, Jannis Kountouras
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
Association between serum alanine transaminase/aspartate aminotransferase (ALT/AST) ratio and cognitive impairment in US older adults
Xinping Wang, Xiaoyan Lu
Research Square (Research Square) (2024)
Open Access
Xinping Wang, Xiaoyan Lu
Research Square (Research Square) (2024)
Open Access
Editorial: Decoding the enigma—Navigating complexity in MASLD management. Authors' reply
Naim Alkhouri, Anne‐Cécile V. Bayne, Naga Chalasani
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 817-818
Closed Access
Naim Alkhouri, Anne‐Cécile V. Bayne, Naga Chalasani
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 817-818
Closed Access
Evaluating Bempedoic Acid for Non-alcoholic Fatty Liver Disease: A Review of Preclinical and Clinical Research
Mohamed Anasdeen S, S Shahinaz, Vijayakumar TM
Cureus (2024)
Open Access
Mohamed Anasdeen S, S Shahinaz, Vijayakumar TM
Cureus (2024)
Open Access
Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms
Shubhrat Purwar, Anam Fatima, Himashree Bhattacharyya, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 9, pp. 1021-1032
Open Access | Times Cited: 1
Shubhrat Purwar, Anam Fatima, Himashree Bhattacharyya, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 9, pp. 1021-1032
Open Access | Times Cited: 1
